Clinical effect of different doses of ciprofol on induction of general anesthesia in elderly patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062838

Enrollment

Unknown

Registered

2022-08-20

Start date

2022-08-20

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

group C1:Ciprofol 0.2 mg/kg

group C2:Ciprofol 0.3 mg/kg

group C3:Ciprofol 0.4 mg/kg

Eligibility

Sex/Gender

All

Age

65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-85 years; 2. ASA (American Association of anesthesiologists) grades are I-II; 3. Patients and their families knew the purpose of this study and voluntarily signed written informed consent; 4. This study was approved by the ethics committee of our hospital.

Exclusion criteria

Exclusion criteria: 1. A history of adverse anesthesia; 2. Combined with bradycardia or other serious cardiovascular diseases; 3. Combined with serious injuries or disorders of important organs such as the lung, brain, liver, and kidney; 4. Combined with serious psychiatric system diseases; 5. History of drug addiction or other drug abuse.

Design outcomes

Primary

Measure	Time frame
Hemodynamics;	—

Secondary

Measure	Time frame
bispectral index;hypertension;hypotension;bradycardia;tachycardia;injection pain;hypoxemia;intraoperative awareness;The onset time of sedation;	—

Countries

China

Contacts

Public ContactWu jimin

Lishui People's Hospital

15240143@qq.com+86 18957091906

Outcome results